The Latest Cardiac and Vascular News
U.S. Approval of the First and Only Nitinol Atherectomy Guide Wire Expands Company’s Portfolio of Products Targeting Complex Coronary Disease ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced […]
Additional clinical evidence to be highlighted at upcoming Controversies in Dialysis Access (CiDA) and American Society of Nephrology (ASN) meetings SAN ANTONIO, Sept. 24, 2019 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of positive results associated […]
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare Dedicated Investors Companies to Hold Conference Call on September 24th at 8:30AM EDT WALTHAM, Mass. and NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) — Proteon […]
LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, has entered into a financing agreement with Goldman Sachs Specialty Lending Group, L.P. (“Goldman Sachs”) involving the placement of Senior Secured Notes due 2024 pursuant to a committed purchase of up to $45 million, comprised […]
CHICAGO–(BUSINESS WIRE)–Chicago-based medical device firm Attune Medical has expanded its pioneering patent portfolio with two major advancements. The USPTO recently issued a broad method patent for Devices and Methods for Controlling Patient Temperature (US Patent number 10,363,162), which is the first patent in the Attune portfolio that specifically claims the […]
DANVERS, Mass.–(BUSINESS WIRE)–The highest court in Germany, the Federal Court of Justice, recently ruled in favor of Abiomed (NASDAQ: ABMD) in a patent challenge filed by Thoratec in 2015 and validated the strengths of Abiomed’s Impella-related patents. These patents are also the subject of a separate patent infringement action Abiomed […]
Improved Functionality Across Four Valve Sizes and Lowest Delivery Profile on the Market, the Evolut PRO+ TAVR System Launches in U.S. as TAVR Patient Population Grows DUBLIN, Sept. 23, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, today announced U.S. Food and Drug Administration […]
Pre-Specified Interim Review Demonstrated Beneficial Changes in Markers of Cardiovascular Health – CRP, LDL, total cholesterol, triglycerides, oxidized LDL, and blood pressure reduced – Interim results support excellent safety profile – Enrollment continues HONOLULU, Sept. 23, 2019 /PRNewswire/ — Cardax, Inc. (OTCQB: CDXI) today announced results from the pre-specified interim review of its […]
TORONTO, Sept. 23, 2019 /PRNewswire/ – Baylis Medical announced today the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped pigtail wire. The device is designed to achieve left-heart access with controlled precision, while reducing the […]
To demonstrate that treatment with the Revivent TC™ System is more effective than Guideline Directed Medical Therapy (GDMT) for the treatment of ischemic heart failure SAN RAMON, Calif., Sept. 23, 2019 /PRNewswire/ — The Revivent TC™ System has continued to deliver impressive results when evaluating post-market data in Europe. The last 35 consecutive cases […]
